116 results in Exploration of Drug Science
Most Downloaded
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Sasikumar Jalajakumari Soumya ... Perumana R. Sudhakaran
Published: September 13, 2024 Explor Drug Sci. 2024;2:567–582
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Review
Lutein and inflammation: a comprehensive review of its mechanisms of action
Paradentavida Prathyusha ... Edakkadath R. Sindhu
Published: January 25, 2025 Explor Drug Sci. 2025;3:100885
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Review
Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens
Chloé O. Sebilleau, Steven J. Sucheck
Published: April 29, 2024 Explor Drug Sci. 2024;2:203–233
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Systematic Review
Utilizing the Ethereum blockchain for retrieving and archiving augmented reality surgical navigation data
Sai Batchu ... Brandon Lucke-Wold
Published: February 28, 2023 Explor Drug Sci. 2023;1:55–63
Open Access
Perspective
Clinical studies with drugs and biologics aimed at slowing or reversing normal aging processes—emerging results and future perspectives
Ricardo P. Garay
Published: April 10, 2024 Explor Drug Sci. 2024;2:144–153
This article belongs to the special issue Recent Advances with Investigational Compounds and Strategies to Delay or Reverse Normal Aging Processes
Open Access
Original Article
Convenient estimation of oxytetracycline and polymyxin B by a novel high-performance liquid chromatography method: development and validation
Tanu Chaudhary ... Dilpreet Singh
Published: February 24, 2023 Explor Drug Sci. 2023;1:6–17
Open Access
Original Article
Bicyclic peptide-enhanced covalent inhibitor of SARS-CoV-2 3CL protease
Qian Wang ... Shiyu Chen
Published: October 17, 2024 Explor Drug Sci. 2024;2:719–733
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Review
Decoding vascular aging: implications for atherosclerosis progression and clinical intervention
Silumbwe Ceaser Wankumbu ... Ming Xu
Published: August 02, 2024 Explor Drug Sci. 2024;2:449–472
Open Access
Original Article
Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies
Juan Manuel Galdopórpora ... María Victoria Tuttolomondo
Published: February 28, 2025 Explor Drug Sci. 2025;3:100895
Open Access
Original Article
From canonical to unique: extension of a lipophilicity scale of amino acids to non-standard residues
Antonio Viayna ... William J. Zamora
Published: July 30, 2024 Explor Drug Sci. 2024;2:389–407
Open Access
Original Article
In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
Nancy Maurya
Published: August 29, 2023 Explor Drug Sci. 2023;1:276–286
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Mini Review
Pain management for the neurosurgical patient in spinal procedures: overview of historic and new modalities
Ashley M. Carter ... Brandon Lucke-Wold
Published: May 21, 2024 Explor Drug Sci. 2024;2:268–276
Open Access
Review
Psoralidin: emerging biological activities of therapeutic benefits and its potential utility in cervical cancer
Tanya Tripathi ... Alok Chandra Bharti
Published: September 24, 2024 Explor Drug Sci. 2024;2:583–613
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Perspective
Plants and fungi metabolites as novel autophagy inducers and senescence inhibitors
Rivka Ofir
Published: July 01, 2024 Explor Drug Sci. 2024;2:361–368
This article belongs to the special issue Remedial benefits of natural products in inflammation and cancer
Open Access
Original Article
Enhanced breast cancer cell targeting: RGD integrin ligand potentiates RWQWRWQWR’s cytotoxicity and inhibits migration
Andrea Barragán-Cárdenas ... Javier García-Castañeda
Published: July 19, 2024 Explor Drug Sci. 2024;2:369–388
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Original Article
Hybrid peptides inspired by the RWQWRWQWR sequence inhibit cervical cancer cells growth in vitro
Natalia Ardila-Chantré ... Javier Eduardo García-Castañeda
Published: September 27, 2024 Explor Drug Sci. 2024;2:614–631
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Review
21st century Latin American synthetic peptides for their application in antivenom production
Jésica A. Rodríguez ... Silvia A. Camperi
Published: September 30, 2024 Explor Drug Sci. 2024;2:648–665
This article belongs to the special issue Bioactive Peptides: Pioneering Innovations in Latin American Research
Open Access
Case Report
Grade IV oral mucositis treatment with Brazilian green propolis mucoadherent gel
Diogo Alvarenga Silva ... Vagner Rodrigues Santos
Published: October 9, 2023 Explor Drug Sci. 2023;1:312–321
Open Access
Mini Review
Advantages of using biofilms to obtain high-value molecules by microbial biotransformations
Nicoly Subtil de Oliveira ... Edvaldo Antonio Ribeiro Rosa
Published: January 14, 2025 Explor Drug Sci. 2025;3:100884
This article belongs to the special issue Greening Drug Manufacturing for a Sustainable Healthcare
Open Access
Editorial
Machine learning for drug science
Walter F. de Azevedo Jr.
Published: April 16, 2023 Explor Drug Sci. 2023;1:77–80
This article belongs to the special issue Machine Learning for Drug Science
Journal Information